baber/WOPTO huggingface dataset:
Patent CA-3101951-A1 (CA)
Inventor: SHITARA Hisataka
IPC: G01N21/3563
Filed: 2018-05-31
Abstract: [Problem] To provide a quality measuring system that can measure the quality of a paper web by separating a flow direction component and a width direction component, that is of a non-scanning and non-filtering method which does not require a conventional basis weight sensor or ash meter using radiation or X-rays, that can be applied from small low-speed paper machines to large high-speed paper machines, and that involves a stable online accuracy confirmation method and correction method for long materials with high cost efficiency. [Solution] In a quality measurement method for a long sheet material W, cellulose fiber, moisture, ash, etc., of a paper web W are measured with area cameras 1102-1106 each having an infrared light receiving element and a light source 1100 having an infrared light emitting LED element. The performance confirmation of the infrared cameras 1102-1106 over the entire width and the correction of the measurement values are performed by using the consistency of the same point measurement values by the adjacent cameras in the overlap area and a comparison sample 1107 at the off-sheet positions provided at both ends.
Patent CA-3106237-A1 (CA)
Title: Ischemic cardiopathy diagnosis assistance system
Inventor: NAKAYAMA MASAFUMI
IPC: A61B5/02
Filed: 2019-07-19
Abstract: An ischemic cardiopathy diagnosis assistance system includes pressure data acquisition means 11 for acquiring pressure data including proximal pressure Pa in a proximal stenotic segment A1 and distal pressure Pd in a distal stenotic segment A2; intracoronary electrocardiogram data acquisition means 12 for acquiring intracoronary electrocardiogram data made up of a local intracoronary artery electrocardiogram in a neighborhood of the distal stenotic segment A2; and computational processing means 14 for finding a pressure ratio Pa/Pd between the proximal pressure Pa and distal pressure Pd at a time suitable for diagnosis of ischemic cardiopathy based on these data. The computational processing means 14 temporally associates the pressure data with the intracoronary electrocardiogram data, estimates an analysis period T during which vascular resistance remains stably low from a waveform of the intracoronary electrocardiogram data, and extract the pressure data of the analysis period T, and finds the pressure ratio Pa/Pd from the pressure data.
Patent CA-3108078-A1 (CA)
Title: Automatic prediction of yields and recommendation of seeding rates based on weather data
Inventor: MERRILL HUNTER R
IPC: G06K9/00
Filed: 2019-07-31
Abstract: A computer-implemented method of predicting yields and recommending seeding rates for subfields with informed risks is disclosed. The method comprises receiving, by a processor, weather data for a first period consisting of a plurality of sub-periods for one or more subfields of a field; for each of the plurality of sub-periods for the one subfield: calculating a moisture stress indicator from the weather data; predicting, for each of a list of seeding rates, a yield from the moisture stress indicator using a trained model; and selecting one of the list of seeding rates based on the list of predicted yields; identifying one of the predicted yields corresponding to the selected seeding rate; determining, by the processor, a risk profile associated with a range of yields for the one subfield based on the predicted yields identified for the plurality of sub-periods; transmitting data related to the risk profile to a device associated with the one subfield.
Patent CA-3110226-A1 (CA)
Inventor: REED QUINTON
IPC: H02P29/02
Filed: 2021-02-23
Abstract: Examples described herein provide a method for overspeed protection of a motor of a gate crossing mechanism. The method includes monitoring, by an overspeed protection circuit, a voltage across a first Zener diode and a second Zener diode. An anode of the first Zener diode is connected to an anode of the second Zener diode. The method further includes, responsive to determining that a Zener voltage threshold is exceeded, allowing a current to flow into a gate pin of a triac. The triac controls the motor of the gate crossing mechanism.
Patent CA-3110706-A1 (CA)
Inventor: VODYANYK MAKSYM
IPC: A61K35/17
Filed: 2019-09-19
Abstract: Provided herein are methods for the activation and expansion of T cells. Further provided are methods for the use of the T cells for therapy.
Patent CA-3111326-A1 (CA)
Title: Systeme de filtration d'eau
Inventor: KRUCKENBERG CHRISTOPHER A
IPC: B01D27/08
Filed: 2012-09-06
Abstract: ABRÉGÉ Une unité de filtre comprend un corps essentiellement cylindrique ayant des extrémités proximales et distales, et de première et seconde surfaces de mise en prise évidées qui comprennent un premier segment sétendant de manière sensiblement parallèle longitudinalement par rapport au corps, un second segment sétendant à un angle entre 50 degrés et 60 degrés à partir du premier segment, et un troisième segment sétendant sensiblement perpendiculairement au premier segment. Un élément de clé sétendant latéralement sur le corps se situe entre les première et seconde surfaces de mise en prise évidées. Une saillie de mise en prise de lextrémité proximale a une paroi latérale ayant une entrée d'eau et au moins un joint détanchéité disposé sur celui-ci et une paroi de mise en prise ayant une sortie d'eau. Une périphérie de la paroi de mise en prise comprend de première et seconde parties ayant un premier rayon de courbure et un second plus grand rayon de courbure, respectivement. Une section transversale de la saillie de mise en prise à travers ledit au moins un joint d'étanchéité a un axe de symétrie unique. Date reçue/Date Received 2021-03-05
Patent CA-3111558-A1 (CA)
Title: Electrosurgical generator control system
Inventor: NGUYEN MICHAEL
IPC: A61B18/12
Filed: 2019-09-05
Abstract: Systems and methods for enhancing surgical outcomes by providing generators having optimal RF output for sealing, fusing and/or cutting tissue or vessels under all dynamic conditions are described. Examples of dynamic conditions may include varying tissue impedance load due to electrosurgical operations or tissue affects, any operational conditions and commands determined by the surgeon, surgical procedure and/or device script. This is achieved by implementing a digital closed-loop control system within the electrosurgical generator to regulate voltage, current, and power of the RF output. The digital closed-loop control system may include an RF amplifier for generating RF energy, a feedback system for constantly monitoring the electrical characteristics, e.g., voltage, current, and power, of the supplied RF energy to a connectable electrosurgical instrument and a microcontroller for processing measurement data from the feedback system and adjusting the output of the RF amplifier to meet a desired regulation target under any varying conditions.
Patent CA-3112019-A1 (CA)
Inventor: WATSON ADRIAN
IPC: A61P17/00
Filed: 2019-09-10
Abstract: La présente invention concerne l'utilisation d'un régime alimentaire ou d'un aliment comprenant de l'acide linoléique à hauteur de 7 g/Mcal à 9 g/Mcal pour maintenir ou améliorer la qualité de la peau d'un animal de compagnie sain. Dans certains modes de réalisation, le régime alimentaire ou l'aliment comprend en outre du zinc à hauteur d'environ 50 mg/Mcal. L'invention concerne en outre un régime alimentaire ou un aliment comprenant de l'acide linoléique à hauteur de 7 g/Mcal à 9 g/Mcal pour une utilisation dans une méthode de traitement d'un animal de compagnie affecté par un trouble ou une maladie de la peau.
Patent CA-3112853-A1 (CA)
Title: Conveyor chain for a pallet belt of a moving walkway of low structural height
Inventor: PRAXMARER DOMINIK
IPC: B66B23/02
Filed: 2019-10-23
Abstract: A conveying chain (5) for a panel belt (3) of a moving walkway (1) is described. The conveying chain has a plurality of elongate chain links (27) which are arranged behind one another with a chain pitch spacing (T1) and are coupled to one another via chain pins (35, 37) so as to be loadable in tension and so as to be pivotable transversely to the direction of extent (17) about a centre longitudinal axis (M) of the respective chain pin (35, 37). Furthermore, the conveying chain (5) has a plurality of elongate attachment elements (39) which are likewise arranged behind one another and pivotably coupled to one another. Each of the attachment elements (39) is coupled at a front end (41) to an associated first one of the chain pins (37) and is coupled at a rear end (43) to an associated second one of the chain pins (37). An attachment element pitch spacing (T2) between the first and the second chain pin (37) is here an integral multiple of the chain pitch spacing (T1).
Patent CA-3113220-A1 (CA)
Title: Combinaison pharmaceutique synergique d'un antagoniste des recepteurs de leucotrienes et d'un agoniste inverse de l'histamine h1
Inventor: GARCIA ARMENTA PATRICIA DEL CARMEN
IPC: A61K31/47
Filed: 2019-09-20
Abstract: La présente invention concerne une composition pharmaceutique qui comprend la combinaison synergique d'un antagoniste des récepteurs de leucotriènes, comme l'est le principe actif : le montélukast et ses sels pharmaceutiquement acceptables et un antagoniste inverse de l'histamine H1, comme l'est le principe actif : la kétotifène et ses sels pharmaceutiquement acceptables, lesquels sont formulés avec des excipients et/ou des véhicules et/ou des additifs pharmaceutiquement acceptables en une seule unité de dosage pour une administration par voie orale, transdermique ou par des dispositifs pour l'inhalation orale, nasale, comme celle indiquée pour le traitement de la maladie atopique comme : l'asthme, la rhinite allergique et la dermatite atopique.
Patent CA-3115253-A1 (CA)
Title: A novel continuous flow reactor for low ph viral inactivation
Inventor: PARKER STEPHANIE
IPC: A61L2/00
Filed: 2019-10-07
Abstract: A viral inactivation device including at least one continuous viral inactivation reactor having an inlet, an outlet, and a tubular flow path. The tubular flow path includes a set of alternating turns that form a serpentine pattern between the inlet and the outlet.
Patent CA-3117825-A1 (CA)
Title: Detection automatisee d'un evenement de comportement physique et ajustement correspondant d'un systeme de distribution de medicament
Inventor: VLEUGELS KATELIJN
IPC: G16H20/10
Filed: 2019-10-30
Abstract: L'invention concerne un système de distribution de médicament automatisé qui permet de déclencher un message d'administration de médicament lorsqu'un événement présumé est détecté pour lequel un message d'administration de médicament doit être envoyé. L'événement peut être le début, le commencement, ou une anticipation d'un début, d'un événement d'ingestion d'aliment, détecté par un module de détection d'événement à partir de gestes d'un utilisateur par un ensemble de lectures de capteur. Le message peut être un signal vers un appareil de distribution de médicament, et/ou un message de rappel à l'utilisateur, un message auxiliaire à un soignant, un professionnel de la santé, ou autres. Le message d'administration de médicament peut comprendre un signal vers une entrée d'un système de gestion d'insuline ou vers une entrée d'un pancréas artificiel sensible aux repas. Les événements peuvent également comprendre un événement d'ingestion de boisson, un événement de tabagisme, un événement d'hygiène personnelle et/ou un événement associé à un médicament.
Patent CA-3119116-A1 (CA)
Title: Transparent protective face mask
Inventor: SUTTON RICHARD
IPC: A41D13/11
Filed: 2021-05-18
Abstract: A transparent protective face mask, typically for non-medical use, is provided. The mask comprises a protective face covering portion to cover at least a mouth and nose of a user; side portions respectively comprising head attachment means; and a mount portion for resting the mask adjacent to and in contact with the chin of the user, whereby the face covering portion of the mask is spaced apart from the face of the user except at the mount portion. In another embodiment, the face mask comprises a flexible chin panel hinged to the face covering portion.  The chin panel is releasably lockable with the face covering portion. The face covering portion may also comprise a nose portion comprising a nose bridge portion, and one or more nose protuberances flanking the nose bridge portion, for engaging with opposite sides of the nose of a user.
Patent CA-3124151-A1 (CA)
Inventor: POSTEL RUBEN
IPC: A61K47/55
Filed: 2019-12-09
Abstract: La présente invention concerne une fraction effectrice capable d'induire un effet intracellulaire lorsqu'elle est présente à l'intérieur d'une cellule de mammifère, la fraction effectrice comprenant une charge utile conjuguée à au moins une saponine. L'invention concerne également un conjugué anticorps-médicament comprenant la fraction effectrice selon l'invention, ou un conjugué ligand-médicament comprenant la fraction effectrice de l'invention, la fraction effectrice comprenant de la saponine couplée de manière covalente. L'invention concerne également une association thérapeutique comprenant : (a) la fraction effectrice de l'invention, comprenant au moins une saponine, et éventuellement un excipient pharmaceutiquement acceptable; et (b) un conjugué anticorps-médicament ou un conjugué ligand-médicament, et éventuellement un excipient pharmaceutiquement acceptable. En outre, l'invention concerne une composition pharmaceutique comprenant la fraction effectrice de l'invention ou le conjugué anticorps-médicament de l'invention ou le conjugué ligand-médicament de l'invention, comprenant au moins une saponine liée de manière covalente à la molécule effectrice, et éventuellement un excipient pharmaceutiquement acceptable. L'invention concerne également la fraction effectrice de l'invention ou le conjugué anticorps-médicament de l'invention ou l'association thérapeutique de l'invention ou le conjugué ligand-médicament de l'invention ou la composition pharmaceutique de l'invention, pour une utilisation en tant que médicament. Enfin, l'invention concerne également la fraction effectrice de l'invention ou le conjugué anticorps-médicament de l'invention ou l'association thérapeutique de l'invention ou le conjugué ligand-médicament de l'invention ou la composition pharmaceutique de l'invention, destiné(e) à être utilisé(e) dans le traitement ou la prévention d'un cancer ou d'une maladie auto-immune.
Patent CA-3124518-A1 (CA)
Title: Structural component for modular walls
Inventor: GOSLING GEOFF WILLIAM
IPC: E04B2/74
Filed: 2020-01-30
Abstract: A reversible structural component for use as a portion of a vertical frame in a modular wall system includes an elongate body extending between a first end and a second end thereof, a plurality of countersunk through-holes extending through the structural component, and a plurality of threaded through-holes extending through the structural component. The countersunk through-holes and the threaded through-holes are disposed on the elongate body between the first end and the second end so that the countersunk through-holes of the structural component are aligned with the threaded through-holes of a separate identical structural component when back sides of the structural component and the separate identical structural component are brought together 180-degrees relative to one another during use.
Patent CA-3126066-A1 (CA)
Inventor: BOLLARD CATHERINE MARY
IPC: C12N5/0783
Filed: 2020-01-07
Abstract: The disclosure provides T-cell compositions, therapies and processes of manufacture that are tailored to the specific antigenic expression of a subjects' tumor and allowing for changes in expression over time based on either pressure from antineoplastic therapy or natural heterogeneous selection. The disclosure also extends to methods of manufacturing such T-cell compositions and the generation of single antigen T-cell banks from healthy donors to provide an improved personalized T-cell therapy.
Patent CA-3126189-A1 (CA)
Inventor: MAERTENS DOMINIC
IPC: G21G1/00
Filed: 2020-01-15
Abstract: In a first aspect, the present invention relates to a method for purifying Ac from a mixture comprising Ac and at least one element selected from Ra, Pb, Po, Bi and La, the method comprising: (a) performing a first separation using a first extraction chromatographic column based on a first resin (either a diglycolamide resin or a dialkylphosphoric acid resin) and a first matrix solution; and (b) performing a second separation using a second extraction chromatographic column based on a second resin (respectively either a dialkylphosphoric acid resin or a diglycolamide resin).
Patent CA-3126503-A1 (CA)
Inventor: GREENE ROBERT
IPC: E06B7/23
Filed: 2021-07-30
Abstract: A weather stripping assembly is provided and includes a first backing member and a second backing member together defining a longitudinal axis, and first and second transverse directions. Each of the backing members includes a channel. The first backing member has a first alignment structure, and the second backing member has a second alignment structure. The first and second alignment structures are engageable with one another to align their channels with one another in the first and second transverse directions. A flexible seal is shaped to be held in and extend along the channels of both the first and second backing members when the at least two of the plurality of backing members are positioned with the first and second alignment structures in engagement with one another such that the channels of the first and second backing members are aligned with one another.
Patent CA-3129117-A1 (CA)
Title: Charged ion channel blockers and methods for use
Inventor: COLE BRIDGET MCCARTHY
IPC: C07D211/34
Filed: 2020-03-11
Abstract: The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof: The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, itch, and neurogenic inflammation.
Patent CA-3129794-A1 (CA)
Inventor: LAU FRANK HO PAK
IPC: A61L27/54
Filed: 2020-03-27
Abstract: L'invention concerne une méthode de prévention ou de réduction de l'apparition et/ou du développement d'une hernie chez un sujet présentant un risque de développer une hernie, consistant à implanter un matériau de greffe en contact avec une ouverture dans une paroi abdominale. Le matériau de greffe favorise la cicatrisation de la paroi abdominale et comprend un tissu placentaire ou dérivé d'un placenta.
Patent CA-3129836-A1 (CA)
Title: Blood-based screen for detecting neurological diseases in primary care settings
Inventor: O'BRYANT SID E
IPC: G16B25/00
Filed: 2020-02-14
Abstract: The present invention includes methods and kits for measuring a level of four or more biomarkers selected from IL1, IL7, TNFa, IL5, IL6, CRP, IL10, TNC, ICAM1, FVII, 1309, TNFR1, A2M, TARC, adiponectin, MIP1, eotaxin3, sVCAMl, TPO, FABP, IL18, B2M, SAA, PPY, DJI, a-synuclein, Ab40, Ab42, tan, alpha-syn, and NfL in a sample separated from a human subject in the primary care setting with neurological disease with a nucleic acid, an immunoassay or an enzymatic activity assay.
Patent CA-3132784-A1 (CA)
Title: Dispositif et procede de traitement de billes de bois utilisant une camera thermique
Inventor: HARINEN MARKO
IPC: G01K13/04
Filed: 2020-03-06
Abstract: L'invention concerne un dispositif de traitement de billes de bois comprenant un appareil de dégivrage (11), un appareil d'écorçage (22), disposé en aval de l'appareil de dégivrage, une caméra thermique (30), disposée pour acquérir une image thermique d'au moins une bille de bois en aval de l'appareil d'écorçage, et un dispositif de traitement (40). Le dispositif de traitement (40) est configuré pour recevoir l'image thermique provenant de la caméra thermique, pour traiter l'image thermique pour déterminer une température de surface de billes de bois et pour fournir un signal de commande de dégivrage à l'appareil de dégivrage (11), en fonction de la température de surface de billes de bois. L'invention concerne également un procédé de traitement de billes de bois.
Patent CA-3133244-A1 (CA)
Inventor: BAER MATTHEW JAMES
IPC: H04N5/225
Filed: 2020-03-12
Abstract: In one aspect, a movable barrier operator includes a housing and a motor. The movable barrier operator further includes a camera mount that is connected to the housing and that supports a camera. The camera mount is configured to facilitate movement of the camera between a storage position wherein at least a portion of the camera is inside the housing and an operative position wherein the at least a portion of the camera is outside of the housing.
Patent CA-3134102-A1 (CA)
Inventor: COUKOS GEORGE
IPC: G01N33/50
Filed: 2020-03-17
Abstract: The application provides genetically modified T cell receptors (TCRs) specific for an epitope from cancer antigen NY-ESO-l. Also provided are related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, and populations of cells, including but not limited to genetically engineered cells, and pharmaceutical compositions. The application further provides the use of such modified T cell receptors (TCRs) and related compositions for cancer immunotherapy (e.g., adoptive cell therapy).
Patent CA-3135849-A1 (CA)
Inventor: FAMILY AFROOZ
IPC: H04S7/00
Filed: 2020-04-02
Abstract: Systems and methods for rendering spatial audio in accordance with embodiments of the invention are illustrated. One embodiment includes a spatial audio system, including a primary network connected speaker, including a plurality of sets of drivers, where each set of drivers is oriented in a different direction, a processor system, memory containing an audio player application, wherein the audio player application configures the processor system to obtain an audio source stream from an audio source via the network interface, spatially encode the audio source, decode the spatially encoded audio source to obtain driver inputs for the individual drivers in the plurality of sets of drivers, where the driver inputs cause the drivers to generate directional audio.
Patent CA-3137345-A1 (CA)
Inventor: KIRMANI MOHAMMAD
IPC: C08F2/02
Filed: 2020-04-17
Abstract: L'invention concerne un procédé de fabrication d'un matériau, selon lequel un système de bismaléimide est chauffé pour générer un liquide de bismaléimide (110). Le liquide de bismaléimide est dégazé (114) pour générer un liquide de bismaléimide dégazé. Un mélange par cisaillement à vitesse élevée et/ou une sonification de sonde sont appliqués au liquide de bismaléimide dégazé pour générer une phase de liquide de bismaléimide hautement mélangé (112). La phase de liquide de bismaléimide hautement mélangé est durcie (116). Un produit de bismaléimide est obtenu par chauffe d'un système de bismaléimide à trois constituants pour générer un liquide de bismaléimide, qui est dégazé dans un vide de 30 mbar jusqu'à ce qu'aucune nouvelle bulle visuellement perceptible ne soit détectée. Le liquide dégazé est mélangé par cisaillement à vitesse élevée à une vitesse de 3 500 tr/min pendant 10 minutes pour générer une phase de liquide de bismaléimide hautement mélangé, qui est durcie pour fabriquer le produit de bismaléimide. Une substance comprend un bismaléimide durci ayant une résistance aux chocs s'inscrivant dans une plage de 56 kJ/m2 à 82 kJ/m2.
Patent CA-3137922-A1 (CA)
Title: Helmet accessory mounting system
Inventor: FRANZINO MICHAEL LAWRENCE
IPC: A42B3/30
Filed: 2020-05-22
Abstract: A helmet accessory mounting system includes a mounting device configured to couple to an outer surface of a side of a helmet. The mounting device includes a plurality of mounting locations configured to removeably couple to at least one accessory. A plurality of the plurality of mounting locations each includes an electrical node. A power supply is coupled to the mounting device. An electrical supply line electrically couples the power supply to each of the electrical nodes and the electrical supply line is contained at least partially within the mounting device.